69 Best Health Tech Startups in United Kingdom to Watch in 2024

Oophthalmic gene therapy company to treat blinding retinal illnesses.

Total Raised: $120.86M

Last Funding: $120.86M (Series A)

Antibody-drug conjugate (ADC) payload platform.

Total Raised: $115.00M

Last Funding: $115.00M (Series A)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Developer of full-spectrum microbial therapeutics.

Total Raised: $51.27M

Last Funding: $0.63M (Seed)

Developer of neurostimulation system to treat swallowing dysfunction.

Total Raised: $52.10M

Last Funding: $42.00M (Series D)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

AI-Powered healthcare platform.

Total Raised: $656.90M

Last Funding: $30.00M (Series B)

Surgical robotic system for minimal access surgery.

Total Raised: $1115.57M

Last Funding: $20.30M (Series A)

Provider of virtual ward and remote patient monitoring services.

Total Raised: $66.20M

Last Funding: $45.90M (Series B)

OS for hospitals and care facilities.

Total Raised: $280.00M

Last Funding: $140.00M (Unknown)

Disease prevention testing platform.

Total Raised: $60.69M

Last Funding: $16.20M (Series A)

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Total Raised: $36.94M

Last Funding: $24.00M (Series B)

Digital health platform for underserved areas people.

Total Raised: $55.98M

Last Funding: $8.50M (Pre Seed)

Digital platform for social care providers.

Total Raised: $8.37M

Last Funding: $3.63M (Unknown)

Platform for advancing neuroscience and neurophysiology solutions.

Total Raised: $9.11M

Last Funding: $2.66M (Seed)

Clinical-stage research for alzheimer’s disease.

Total Raised: $66.45M

Last Funding: $58.65M (Series A)

Biotech firm addresses underserved dental care needs.

Total Raised: $6.29M

Last Funding: $6.29M (Series A)

Oncology drug discovery platform.

Total Raised: $11.43M

Last Funding: $11.43M (Seed)

Small molecule neoantigen immuno-oncology therapies developer.

Total Raised: $12.17M

Last Funding: $12.17M (Series B)

RNA sequencing platform.

Total Raised: $10.79M

Last Funding: $10.79M (Seed)

Building the most advanced global infrastructure for People Science.

Total Raised: $32.46M

Last Funding: $32.46M (Series A)

Workflow automation platform for the life sciences industry.

Total Raised: $49.50M

Last Funding: $2.10M (Seed)

AI-powered mental health platform.

Total Raised: $14.15M

Last Funding: $0.15M (Pre Seed)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

AI-powered mental health assessment platform.

Total Raised: $7.06M

Last Funding: $5.10M (Series A)

Manufacturing platform designed to help patients access lifesaving treatments.

Total Raised: $130.00M

Last Funding: $100.00M (Series B)

3D printed micro-tumor technology developer.

Total Raised: $5.85M

Last Funding: $5.34M (Seed)

Digital health platform for predictive care and research.

Total Raised: $235.00M

Last Funding: $80.00M (Series D)

Virtual surgical theaters platform.

Total Raised: $118.00M

Last Funding: $80.00M (Series C)

Skin care telehealth platform.

Total Raised: $52.00M

Last Funding: $52.00M (Series B)

Cirdan is a provider of informatics software and imaging solutions founded in 2010 by Hugh Cormican .

Total Raised: $12.55M

Last Funding: $9.75M (Series A)

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

Total Raised: $188.00M

Last Funding: $120.00M (Series B)

Robotic-assisted surgery technlogy developer.

Total Raised: $3.12M

Last Funding: $3.12M (Seed)

Primary administrative task automation platform for NHS registrations.

Total Raised: $3.45M

Last Funding: $3.45M (Seed)

Veterinary diagnostic testing solutions provider.

Total Raised: $4.00M

Last Funding: $4.00M (Series A)

AI memory care platform.

Total Raised: $3.40M

Last Funding: $3.40M (Pre Seed)

Generative AI platform for doctors.

Total Raised: $4.17M

Last Funding: $4.17M (Seed)

Clinical trials platform.

Total Raised: $22.80M

Last Funding: $18.00M (Series A)

Data-driven health platform for women.

Total Raised: $1.94M

Last Funding: $0.33M (Pre Seed)

Advanced cell analysis solution for the biopharma industry.

Total Raised: $7.05M

Last Funding: $5.11M (Series A)

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

Total Raised: $201.00M

Last Funding: $17.00M (Seed)

Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle.

Total Raised: $257.50M

Last Funding: $200.00M (Series C)

Medical imaging software.

Total Raised: $19.00M

Last Funding: $19.00M (Series C)

Digital online pharmacy.

Total Raised: $14.95M

Last Funding: $14.95M (Series A)

Lab-quality diagnostics for anyone, anywhere, at any time.

Total Raised: $170.00M

Last Funding: $85.00M (Unknown)

Fresha is a beauty and wellness booking platform founded in 2015 by William Zeqiri.

Total Raised: $120.00M

Last Funding: $100.00M (Unknown)

Digital healthcare program for people with ADHD.

Total Raised: $13.98M

Last Funding: $11.00M (Series A)

Immunotherapy for bladder cancer.

Total Raised: $30.00M

Last Funding: $30.00M (Series B)

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

Total Raised: $36.92M

Last Funding: $18.19M (Unknown)

Arthritis treatment using engineered human stem cells.

Total Raised: $1.78M

Last Funding: $1.78M (Seed)

Quantum simulation platform for drug discovery.

Total Raised: $2.24M

Last Funding: $2.24M (Seed)

Platform focused on utilizing the body's natural immune control mechanisms.

Total Raised: $97.04M

Last Funding: $97.04M (Series B)

Instruments for non-contact optical research, design, and production.

Total Raised: $1.63M

Last Funding: $1.63M (Seed)

Precision software for eye surgery.

Total Raised: $8.11M

Last Funding: $8.11M (Seed)

Pocket-sized brain monitor developer to detect seizures in newborn babies.

Total Raised: $2.10M

Last Funding: $2.10M (Seed)

Digital platform to run in-silico simulations for new and existing medicines.

Total Raised: $1.40M

Last Funding: $1.40M (Seed)

Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Platform enabling the development of cell therapies through advanced reprogramming techniques.

Total Raised: $13.70M

Last Funding: $10.00M (Series A)

Platform for understanding and defining the biological codes that make up human cells.

Total Raised: $144.50M

Last Funding: $103.00M (Series B)

Smart technology manufacturer for women.

Total Raised: $131.76M

Last Funding: $6.30M (Series A)

Cell therapy firm specializing in developing treatments using advanced cellular technology.

Total Raised: $201.03M

Last Funding: $156.00M (Series B)

Developer of novel Treg therapies to treat inflammatory disorders.

Total Raised: $0.84M

Last Funding: $0.84M (Pre Seed)

Mental health platform for employees.

Total Raised: $63.02M

Last Funding: $1.70M (Pre Seed)

Sensor networks for real-time remote monitoring of large infrastructure assets.

Total Raised: $10.56M

Last Funding: $10.06M (Series A)

Biotechnology platform focused on rejuvenating transplant livers.

Total Raised: $39.75M

Last Funding: $30.00M (Series A)

Cancer diagnostics.

Total Raised: $10.78M

Last Funding: $9.25M (Series A)

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

Total Raised: $42.50M

Last Funding: $40.00M (Series A)

Healthcare provider specializing in incontinence awareness and breaking bladder taboos.

Total Raised: $6.94M

Last Funding: $4.23M (Seed)

New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC).

Total Raised: $50.57M

Last Funding: $40.27M (Series B)